PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
$300,728N01FY2024CANIH
Iit Research Institute, Chicago IL
Investigators
Abstract
Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other Indications.
View original record on NIH RePORTER →